Literature DB >> 28858043

Clinical Manifestations of Cryptosporidiosis and Identification of a New Cryptosporidium Subtype in Patients From Sonora, Mexico.

Alejandro Urrea-Quezada1, Mariana González-Díaz1, Isaac Villegas-Gómez1, María Durazo2, Jesús Hernández3, Lihua Xiao4, Olivia Valenzuela1.   

Abstract

The aim of this study was to identify the clinical manifestations of cryptosporidiosis and the distribution of Cryptosporidium spp. and subtypes in children in Sonora, Mexico. Two subtypes of C. parvum, including IIaA15G2R1 and IIcA5G3a, and 6 subtypes of Cryptosporidium hominis, including IaA14R3, IaA15R3, IbA12G3, IdA23, IeA11G3T3, and a new subtype IaA14R11, were identified. Cryptosporidium as an etiologic agent for acute gastroenteritis is discussed.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28858043     DOI： 10.1097/INF.0000000000001762

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  4 in total

1.  Enteric parasitic infection disturbs bacterial structure in Mexican children with autoantibodies for type 1 diabetes and/or celiac disease.

Authors:  Ana M Calderón de la Barca; Reyna S Castillo-Fimbres; María Esther Mejía-León; Luis Quihui-Cota; Adrián Ochoa-Leyva; Sandra V Aguayo-Patrón
Journal:  Gut Pathog       Date:  2020-08-11       Impact factor: 4.181

Review 2.  Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries.

Authors:  Xin Yang; Yaqiong Guo; Lihua Xiao; Yaoyu Feng
Journal:  Clin Microbiol Rev       Date:  2021-02-24       Impact factor: 26.132

3.  Serum IgG Responses to gp15 and gp40 Protein-Derived Synthetic Peptides From Cryptosporidium parvum.

Authors:  Alejandro Urrea-Quezada; Ruben Balmaceda-Baca; Adriana Garibay; Jesús Hernández; Olivia Valenzuela
Journal:  Front Cell Infect Microbiol       Date:  2022-01-19       Impact factor: 5.293

4.  Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil.

Authors:  Flávia de Souza Cunha; Higor Wilson Jann; Jocemir Ronaldo Lugon; José Mauro Peralta; Regina Helena Saramago Peralta
Journal:  Rev Soc Bras Med Trop       Date:  2022-04-08       Impact factor: 2.141
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.